Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Location: Denver CO, Duarte CA, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06292780
Phase 1, Phase 2, Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Duarte CA, Houston TX, Milwaukee WI,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors
for
Solid Tumor, Adult
Location: Denver CO, Aurora CO, Saint Louis MO, Houston TX,
Sponsor: Ribon Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04053673
Phase 1, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Denver CO, Santa Fe NM, Salt Lake City UT, Lubbock TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Denver CO, Scottsdale AZ, Dallas TX, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Denver CO, Los Angeles CA, Houston TX, Sacramento CA,
Sponsor: Prelude Therapeutics Incorporated
Sex: All
Age: 18+
Code: NCT07469891
Phase 1, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Kansas City KS,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Phoenix AZ, Iowa City IA,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase 2, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Denver CO, Aurora CO, Salt Lake City UT, Omaha NE,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT07188558
Phase 3, Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Denver CO, Austin TX, San Antonio TX, San Diego CA,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase 1, Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML